SecBot SecBot
144 ·Filed Nov 6, 2026

PRCT

PROCEPT BioRobotics Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed10d 11h ago SEC0001959173-26-007827
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

This is a mandatory sell-to-cover transaction for tax withholding, not a discretionary insider sale. No bearish signal. Monitor future Form 4 filings for any unplanned insider sales.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$20.62
T+0 close · Nov 6, 2026 · via day close
Latest settled
+15.42%
T+5 · $23.80
Vs SPY
+12.83%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $20.62entry
  2. T+1 · 8d ago +8.49%α +6.12% · $22.37
  3. T+5 · 4d ago +15.42%α +12.83% · $23.80
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Pooja Sharma, an officer of PROCEPT BioRobotics, filed a Form 144 notice of intent to sell 4,710 shares of common stock, valued at approximately $92,553 based on the filing date. The sale is to cover a tax obligation from a vested equity award settlement, not a discretionary insider exit.

Key Facts

  • Filer: Pooja Sharma, an officer of PROCEPT BioRobotics Corp
  • Shares to be sold: 4,710 shares of common stock
  • Approximate value: $92,553.41
  • Reason: sale to cover tax obligation from vested equity award settlement
  • Proposed sale date: November 6, 2026
  • Shares acquired on November 5, 2026 via restricted stock vesting from the issuer

Financial Impact

Approximately $92,553 (4,710 shares at ~$19.65/share based on the filing value), representing a small fraction of the $1.2B market cap and a routine tax-withholding sale.

dilution

Risk Factors

  • No additional risks identified; the sale is mandatory and small relative to market cap.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
48% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-007827
Document: 0001959173-26-007827-index.html0001959173-26-007827
Document: 0001959173-26-007827.txt0001959173-26-007827

Track record

16 reports on PRCT

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +22.73% at T+60 after the Feb 26, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 6, 202610d ago 144 Neutral 2/10 Viewing Entry $20.62 Now $23.54 +14.16% settles Feb 4
  2. Nov 4, 202612d ago 8-K Neutral 5/10 Entry $20.27 Now $23.54 +16.13% settles Feb 3
  3. Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $19.20 Now $23.54 +22.60% settles Jan 28
  4. Oct 2, 20266w ago 8-K Neutral 2/10 Entry $17.82 Now $23.54 +32.10% settles Dec 30
  5. Sep 24, 20267w ago 8-K Neutral 3/10 Entry $17.20 Now $23.54 +36.86% settles Dec 21
  6. Aug 10, 202614w ago Insider Buy Bullish 5/10 Entry $21.71 to $19.98 Now $23.54 +8.43% ▼ −7.99% −6.09% vs SPY
  7. Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $27.69 to $21.35 Now $23.54 −14.99% ▼ −22.90% −26.72% vs SPY
  8. Jun 10, 202622w ago Insider Cluster Neutral 2/10 Entry $27.69 to $21.35 Now $23.54 −14.99% ▼ −22.90% −26.72% vs SPY
  9. Jun 10, 202622w ago Insider Cluster Neutral 2/10 Entry $27.69 to $21.35 Now $23.54 −14.99% ▼ −22.90% −26.72% vs SPY
  10. Jun 10, 202622w ago Insider Cluster Neutral 2/10 Entry $27.69 to $21.35 Now $23.54 −14.99% ▼ −22.90% −26.72% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 6h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026